SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (SABS)

Q: What does CUSIP 78397T202 represent in this 13F holders report?

CUSIP 78397T202 is the security identifier for SABS - SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held SABS - SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share in Q4 2023?

3 institutional investors reported SABS - SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share for Q4 2023. Use the holders table for investor-level position and value details.

CUSIP: 78397T202

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 67,297,118
Total 13F shares: 8,791,109
Share change: +8,791,109
Total reported value: $6,055,351
Price per share: $0.69
Number of holders: 3
Value change: +$6,055,351
Number of buys: 3

Quarterly Holders Quick Answers

What is CUSIP 78397T202?
CUSIP 78397T202 identifies SABS - SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024

Recent filing periods for CUSIP 78397T202:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SABS - SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Edward D. Hamilton	3/4/5	10%+ Owner	— mixed-class rows	9,456,382 mixed-class rows	$9,348,396	—	22 Oct 2021	3/4/5
Ilan Katz	3/4/5	Director, 10%+ Owner	— class O/S missing	3,049,325	$2,683,406	—	13 Oct 2021	3/4/5
VANGUARD GROUP INC	13F	Company	— class O/S missing	976,938	$615,471	—	30 Sep 2023	13F
First PREMIER Bank	13F	Company	— class O/S missing	807,535	$509,000	—	30 Sep 2023	13F
PATHSTONE FAMILY OFFICE, LLC	13F	Company	— class O/S missing	506,513	$319,103	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	356,364	$224,581	—	30 Sep 2023	13F
FIRST MANHATTAN CO. LLC.	13F	Company	— class O/S missing	277,777	$174,999	—	30 Sep 2023	13F
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC	13F	Company	— class O/S missing	192,027	$120,977	—	30 Sep 2023	13F
STATE STREET CORP	13F	Company	— class O/S missing	81,241	$51,182	—	30 Sep 2023	13F
HighTower Advisors, LLC	13F	Company	— class O/S missing	73,470	$46,000	—	30 Sep 2023	13F
Mariner, LLC	13F	Company	— class O/S missing	69,000	$43,470	—	30 Sep 2023	13F
LMR Partners LLP	13F	Company	— class O/S missing	539,588	$37,771	—	30 Sep 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— class O/S missing	58,100	$37,000	—	30 Sep 2023	13F
BlackRock Finance, Inc.	13F	Company	— class O/S missing	52,643	$33,165	—	30 Sep 2023	13F
Shaolin Capital Management LLC	13F	Company	— class O/S missing	465,717	$33,000	—	30 Sep 2023	13F
PEAPACK GLADSTONE FINANCIAL CORP	13F	Company	— class O/S missing	52,296	$33,000	—	30 Sep 2023	13F
Creative Planning	13F	Company	— class O/S missing	47,518	$29,936	—	30 Sep 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	— class O/S missing	46,673	$29,403	—	30 Sep 2023	13F
NORTHERN TRUST CORP	13F	Company	— class O/S missing	44,476	$28,020	—	30 Sep 2023	13F
MORGAN STANLEY	13F	Company	— mixed-class rows	164,345 mixed-class rows	$20,132	—	30 Sep 2023	13F
Brookstone Capital Management	13F	Company	— class O/S missing	21,755	$17,350	—	30 Sep 2023	13F
LGL PARTNERS, LLC	13F	Company	— class O/S missing	23,000	$14,490	—	30 Sep 2023	13F
Kestra Advisory Services, LLC	13F	Company	— class O/S missing	21,000	$13,230	—	30 Sep 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	— class O/S missing	16,238	$10,230	—	30 Sep 2023	13F
Strategic Financial Concepts, LLC	13F	Company	— class O/S missing	15,027	$9,467	—	30 Sep 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	— mixed-class rows	14,988 mixed-class rows	$9,416	—	30 Sep 2023	13F
Nadler Financial Group, Inc.	13F	Company	— class O/S missing	13,750	$8,663	—	30 Sep 2023	13F
Yakira Capital Management, Inc.	13F	Company	— class O/S missing	108,485	$8,136	—	30 Sep 2023	13F
Elgethun Capital Management	13F	Company	— class O/S missing	9,935	$6,358	—	30 Sep 2023	13F
1ST SOURCE BANK	13F	Company	— class O/S missing	10,000	$6,300	—	30 Sep 2023	13F
Baird Financial Group, Inc.	13F	Company	— class O/S missing	10,000	$6,300	—	30 Sep 2023	13F
ROYAL BANK OF CANADA	13F	Company	— class O/S missing	4,820	$3,000	—	30 Sep 2023	13F
Walleye Capital LLC	13F	Company	— class O/S missing	23,258	$1,628	—	30 Sep 2023	13F
GS Investments, Inc.	13F	Company	— class O/S missing	2,000	$1,260	—	30 Sep 2023	13F
Walleye Trading LLC	13F	Company	— class O/S missing	15,505	$1,085	—	30 Sep 2023	13F
WOLVERINE ASSET MANAGEMENT LLC	13F	Company	— class O/S missing	12,765	$893	—	30 Sep 2023	13F
JPMORGAN CHASE & CO	13F	Company	— class O/S missing	927	$584	—	30 Sep 2023	13F
HARBOUR INVESTMENTS, INC.	13F	Company	— class O/S missing	500	$315	—	30 Sep 2023	13F
FMR LLC	13F	Company	— class O/S missing	343	$216	—	30 Sep 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	— class O/S missing	268	$169	—	30 Sep 2023	13F
NewEdge Advisors, LLC	13F	Company	— mixed-class rows	1,217 mixed-class rows	$166	—	30 Sep 2023	13F
Qube Research & Technologies Ltd	13F	Company	— class O/S missing	69	$43	—	30 Sep 2023	13F
Russell P. Beyer	3/4/5	Chief Financial Officer	— class O/S missing	275,000	—	—	14 Mar 2023	3/4/5
Charles Hiram Randall	3/4/5	Chief Strategy Officer	— mixed-class rows	157,313 mixed-class rows	—	—	22 Oct 2021	3/4/5
Mervyn Turner	3/4/5	Director	— mixed-class rows	79,192 mixed-class rows	—	—	22 Oct 2021	3/4/5
Hua Wu	3/4/5	SVP Research & Product Dev.	— mixed-class rows	43,823 mixed-class rows	—	—	22 Oct 2021	3/4/5
Frederick Finnegan	3/4/5	Chief Business Officer	— class O/S missing	23,453	—	—	16 Mar 2022	3/4/5
Thomas Charles Luke	3/4/5	Chief Medical Officer	— class O/S missing	20,519	—	—	16 Mar 2022	3/4/5
Bruce Kipp Erickson	3/4/5	Chief Operating Officer	— class O/S missing	18,196	—	—	16 Mar 2022	3/4/5
Carlos N. Carillo	3/4/5	SVP Regulatory Affairs	— class O/S missing	17,681	—	—	22 Oct 2021	3/4/5

Institutional Holders of SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (SABS) as of Q4 2023

As of 31 Dec 2023, SAB Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (SABS) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,791,109 shares. The largest 3 holders included MARSHALL WACE, LLP, RA CAPITAL MANAGEMENT, L.P., and COMMODORE CAPITAL LP. This page lists 3 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q4 2025 Across Filers

Q4 2025 holders

Q4 2023 holders

Holder diff

-45

Investor	Q4 2025 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.